AUGUST 2010
30 August 2010 Appendix 4E & 2010 Annual Report
26 August 2010 Patrys Newsletter
12 August 2010 Patrys Expands Executive Management Team
3 August 2010 Patrys Secures Funding of up to A$15 Million
2 August 2010 Patrys PAT-SM6 Melanoma Human Trial Approved
JULY 2010
28 July 2010 Patrys Acquires Promising Therapeutic Candidate
6 July 2010 Patrys Granted Key U.S. Patent on Lead Product
JUNE 2010
18 June 2010 Patrys Expands Product Pipeline
MAY 2010
28 May 2010- Patrys Reaches First Milestone in CSL Collaboration
24 May 2010 Patrys PAT-SM6 Clinical Trial Update
MARCH 2010
25 March 2010 Patrys Activity Update/Newsletter
FEBRUARY 2010
26 February 2010 Half Year Results - December 2009
24 February 2010 Patrys Granted Key Patent
JANUARY 2010
28 January 2010 Patrys CSL Collaboration
NOVEMBER 2009
27 November 2009 CEOs Presentation to AGM 2009
11 November 2009 Patrys Awarded Grant for Clinical Candidate PAT-SM6
OCTOBER 2009
27 October 2009 Notice of 2009 Annual General Meeting
27 October 2009 CEO Presentation at AusBiotech Life Sciences Investment Summit
6 October 2009 Patrys Acquires Human Product SC1
SEPTMEBER 2009
22 September 2009 CEO Investor Presentation
16 September 2009 PAT-SM6 Prevents Colon Cancer Metastases
AUGUST 2009
28 August 2009 Annual Report
24 August 2009 Preclinical Development of PAT-SM6 and PAT-LM1 Finalised
17 August 2009 Rights Issue $5 million raised
JULY 2009
10 July 2009 Rights Issue Offer Documentation Mailed to Shareholders
10 July 2009 Rights Issue Offer Documents
1 July 2009 Shareholder Teleconference & Webcast Presentation
JUNE 2009
30 June 2009 Patrys update via Teleconference & Webcast
29 June 2009 Patrys announces $6.8 million rights issue
29 June 2009 Appendix 3B – Rights Issue
29 June 2009 Shareholder Letter & Notice of EGM
29 June 2009 Update on Key Activities
29 June 2009 Cleansing Statement
15 June 2009 Successful Safety Studies for Lead Products PAT-LM1
and PAT-SM6
MAY 2009
25 May 2009 - Patrys commences safety studies for two lead products
FEBRUARY 2009
27 February 2009 - Patrys Presents at Scientific Conferences
25 February 2009 - Half Year Results December 2008
DECEMBER 2008
23 December 2008 - Appointment of Company Secretary
15 December 2008 - Patrys-Challenge Fundraiser
5 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
3 December 2008 - Patrys Completes Acquisition of Technologies and US$2million
3 December 2008 - Manufacturer Wuxi AppTec Announces Rationalisation Plan
NOVEMBER 2008
28 November 2008 - Results of Annual General Meeting
28 November 2008 Appendix 3B
27 November 2008 - Chairmans address to shareholders
27 November 2008 - CEOs presentation to AGM
13 November 2008 - Five Patrys lead products demonstrate therapeutic potential
OCTOBER 2008
30 October 2008 Appendix 4C Quarterly
29 October 2008 Patrys Ltd to acquire assets of Acceptys, Inc
29 October 2008 Notice of Annual General Meeting and Final Annual Report
SEPTEMBER 2008
30 September 2008 Annual Report
AUGUST 2008
29 August 2008 Appendix 4E Preliminary Financial Report
JULY 2008
31 July 2008 Appendix 4C quarterly
31 July 2008 CEO presentation at 6th Annual Australian Biotechnology Summit
9 July 2008 - Becoming a substantial shareholder of PAB
JUNE 2008
30 June 2008 - Release of Securities from Escrow
23 June 2008 - Online Newsletter
APRIL 2008
24 April 2008 - Appendix 4C quarterly
24 April 2008 - Release of Options from Escrow
21 April 2008 - CEO presentation at Excellence in Biotechnology Investment
09 April 2008 - CEO presentation Lodge Mid Cap Confab
07 April 2008 - Patrys Ltd CEO on Strategy and Outlook update
03 April 2008 - Trading volume update
MARCH 2008
28 March 2008 - Becoming a substantial holder for PAB
FEBRUARY 2008
28 February 2008 - Appendix 4D and Half Yearly Report
08 February 2008 - Becoming a substantial shareholder
JANUARY 2008
31 January 2008 - Commencement of Scale-up Manufacturing of Lead Product
31 January 2008 - Acceptys and Seattle Biomedical Research Institute Join in Fight Against Malaria
31 January 2008 - Appendix 4C quarterly
14 January 2008 - Release from escrow
DECEMBER 2007
14 December 2007 - Online newsletter
NOVEMBER 2007
26 November 2007 - Results of Annual General Meeting
19 November 2007 - CEO Annual Shareholders Presentation
19 November 2007 -Chairman's address 2007 Annual General Meeting
OCTOBER 2007
30 October 2007 - Quarterly report for entities admitted on the basis of commitments
10 October 2007 - Notice of General Meeting
SEPTEMBER 2007
28 September 2007 -
Takeda elects to expand Patrys antibody development collaboration
AUGUST 2007
30 August 2007 - Preliminary Financial Report- Year Ended 30 June 2007
JULY 2007
31 July 2007 - Appendix 4C Quarterly report for entities admitted on the basis of commitments
31 July 2007 - Takeda Advances Collaboration & Completes Additional Investment in Patrys
25 July 2007 - Notice of initial substantial holder
25 July 2007 - Notice of initial substantial holder
12 July 2007 - Notice of initial substantial holder
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
13 July 2007 - Successful Listing for Human Antibody Therapeutics Company
13 July 2007 - Option Terms and Conditions
12 July 2007 - Appendix 1A - ASX Listing application and agreement
12 July 2007 - Constitution of Patrys Limited
12 July 2007 - Series 2 Options Terms and conditions of issue
12 July 2007 - PRE-QUOTATION DISCLOSURE
12 July 2007 - ADMISSION TO ASX OFFICIAL LIST AND RELATED DISCOLUSURES
12 July 2007 - COMMENCEMENT OF OFFICIAL
QUOTATION
